Pleasanton – September 07, 2026 -- Veeva Systems (NYSE: VEEV) has launched Veeva Falcon Safety, an AI agent product designed to streamline adverse event intake, case processing and follow-up for biopharmaceutical companies of all sizes, cutting costs while maintaining regulatory compliance.
Falcon Safety Integrates With Any E2B-Compatible System Across All Intake Channels
Beyond seamless integration with Veeva Safety, Falcon Safety will handle initial intake and follow-up management for any E2B-compatible safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.
Veeva Positions Product as Part of Its Life Sciences AI Portfolio
Falcon Safety is part of Veeva AI, the company's line of artificial intelligence solutions built specifically for the life sciences sector.
Marius Mortensen, Vice President of Product for Falcon at Veeva, said the company worked closely with case managers, pharmacovigilance experts and safety specialists worldwide to develop Veeva Safety, and is now consolidating that collaboration through Falcon Safety to help the industry reinvent its safety operations.
Early Availability Set for November 2026
Falcon Safety is scheduled for early availability to select users starting in November 2026.